Article
Neurodevelopmental signature of a transcriptome-based polygenic risk score for depression.
Psychiatry research - 1 Sept 2024
Miles Amy E, Rashid Sarah S, Dos Santos Fernanda C, Clifford Kevan P, Sibille Etienne, Nikolova Yuliya S
Abstract excerpt
Disentangling the molecular underpinnings of major depressive disorder (MDD) is necessary for identifying new treatment and prevention targets. The functional impact of depression-related transcriptomic changes on the brain remains relatively unexplored. We recently developed a novel transcriptome-based polygenic risk score (tPRS) composed of genes transcriptionally altered in MDD. Here, we sought to investigate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
